Coming to San Diego, CA for the first time, the 5th Induced Proximity-Based Drug Discovery Summit returns as your intimate learning and networking setting to cover the depth and breadth of proximity-based drugs from stabilization, phosphorylation and methylation to novel lysosome-based degradation to finally drug the undruggable.

Enabling leaders in biopharma and academia to identify novel MoAs, leverage advanced technologies to find targets more efficiently, and optimize chemical structures for more effective therapeutic agents for a wide range of disease areas. Alongside key strategic updates on DUBTACs, RIPTACs, tPRIMEs, RiboTACs and more, it provides granular technical and scientific insights to overcome challenges in accessing diverse chemical matter and designing selective, potent small molecules of tomorrow.

Join 70+ experts in drug discovery, medicinal chemistry, chemical biology and structural biology from leading companies such as Genentech, Halda Therapeutics and Stablix and gain access to genuinely innovative research from breakthrough companies and academic labs pioneering the next generation of induced proximity-based drugs beyond the ubiquitin proteasome system

Download the event guide for full details: https://ter.li/blor1c